Engineered FcRn Binding Fusion Peptides Significantly Enhance the Half-Life of a Fab Domain in Cynomolgus Monkeys

药代动力学 新生儿Fc受体 融合蛋白 肽 小分子 计算生物学 化学 受体 单克隆抗体 药理学 药效学 环肽 生物化学 抗体 免疫球蛋白G 重组DNA 生物 免疫学 基因
作者
Amita Datta‐Mannan,Jeffrey S. Boyles,Lihua Huang,Zhiying Jin,Amber Peariso,Anthony Murphy,Bernice Ellis,Nicole E. Douglass,Fariba Norouziyan-Cooper,Derrick R. Witcher
出处
期刊:Biotechnology Journal [Wiley]
卷期号:14 (3): 1800007-1800007 被引量:10
标识
DOI:10.1002/biot.201800007
摘要

There is a rapidly growing reinvigoration of the investigation of small proteins, cyclic peptides, and mAb derived domains as biotherapies. The drugability of these structures are challenged by fast peripheral clearance properties that can reduce their potential to be realized as medicines. Engineering strategies have been of limited value because mechanistically the half-life benefit is manifested by increasing the molecular weight and/or the hydrodyanimc radius which slows the molecule's renal elimination, but can result in the inherent loss of activity and target accessibility. The present work evaluated an alternative approach using smaller peptide sequences which bind to the neonatal Fc receptor (FcRn). Results revealed, small linear and cyclic FcRn binding peptides (FcRnBPs) fused to a combination of the N- and C-termini of a Fab can significantly improve the pharmacokinetics of the protein in cynomolgus monkeys relative to the parental Fab. The linear and cyclic conformations, as well as, the number of FcRnBPs fused to the Fab both influence the clearance and the extent of pharmacokinetic benefit. FcRnBP fusion protein kinetics were also affected by a combination of post-translation modifications and non-specific binding properties. The results in this report lay some foundation in fostering the advent of newer technologies toward successfully improving the pharmacokinetics of proteins, peptides, and mAb-derived domains. Additional work in the integration of a variety of factors including the intended site of action, tissue disposition, metabolism, toxicity and pharmacokinetic, and pharmacodynamics relationship of the intended therapeutic modality are key areas for advancement of these approaches.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
温白开完成签到,获得积分10
刚刚
彭于晏的应助被RR采纳,获得20
刚刚
1秒前
隐形曼青的应助被hong采纳,获得10
1秒前
1秒前
aaa发布了新的文献求助10
1秒前
1秒前
Jun的应助被火星上映阳采纳,获得20
1秒前
2秒前
天天向上的应助被li采纳,获得10
3秒前
碧烟完成签到 ,获得积分10
4秒前
4秒前
Zoe完成签到,获得积分10
5秒前
6秒前
6秒前
雾绕完成签到,获得积分20
6秒前
6秒前
6秒前
嵤麈发布了新的文献求助10
6秒前
7秒前
wl321完成签到,获得积分10
7秒前
7秒前
8秒前
8秒前
所所的应助被maT采纳,获得10
8秒前
nana湘完成签到,获得积分10
8秒前
孤独的鸟发布了新的文献求助10
8秒前
9秒前
Hiphone发布了新的文献求助10
9秒前
Jasper的应助被怡然缘分采纳,获得10
9秒前
三七发布了新的文献求助10
10秒前
nana湘发布了新的文献求助10
10秒前
10秒前
小二郎的应助被叶心采纳,获得10
10秒前
希望天下0贩的0的应助被chs110采纳,获得10
11秒前
雾绕发布了新的文献求助10
11秒前
香蕉觅云的应助被Crazy_Runner采纳,获得10
11秒前
11秒前
树有麋鹿发布了新的文献求助10
11秒前
wuyisha完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178280
求助须知:如何正确求助?哪些是违规求助? 9569046
关于积分的说明 21802436
捐赠科研通 7773138
什么是DOI,文献DOI怎么找? 3432735
关于科研通互助平台的介绍 2556770
邀请新用户注册赠送积分活动 2478274